🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Bausch Health Companies Inc. (BHC)
NYSE: BHC · Real-Time Price · USD
8.56
-0.17 (-1.95%)
At close: Nov 19, 2026, 4:00 PM EST
8.40
-0.16 (-1.87%)
After-hours: Nov 19, 2026, 4:01 PM EST

Bausch Health Companies Stock Forecast

Stock Price Forecast

According to 7 analysts polled by S&P Global, Bausch Health Companies stock has a consensus rating of "Hold" and an average price target of $8.40. The average 1-year stock price forecast is 1.87% lower than the current stock price, while the lowest is $7.00 (-18.22%) and the highest is $10 (+16.82%).

Price Target: $8.40 (-1.87%)
Analyst Consensus: Hold

Price Target

Chart
TargetLowAverageMedianHigh
Price$7.00$8.40$8.00$10
Change-18.22%-1.87%-6.54%+16.82%

Analyst Ratings

The average analyst rating for Bausch Health Companies stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Chart
RatingJun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Strong Buy000000
Buy000000
Hold777777
Sell000000
Strong Sell000000
Total777777

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Barclays
Barclays
Hold
Maintains
$7 → $9
HoldMaintains$7 → $9+5.14%Nov 11, 2026
Jefferies
Jefferies
Hold
Reiterates
$6.5 → $8
HoldReiterates$6.5 → $8-6.54%Oct 29, 2026
RBC Capital
RBC Capital
Hold
Reiterates
$10
HoldReiterates$10+16.82%Oct 29, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
11.03B
from 10.27B
Increased by 7.43%
Revenue Next Year
10.96B
from 11.03B
Decreased by -0.66%
EPS This Year
4.91
from 3.75
Increased by 30.97%
EPS Next Year
4.34
from 4.91
Decreased by -11.53%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
8.43B8.12B8.76B9.63B10.27B11.03B
Revenue Growth
5.07%-3.68%7.79%9.91%6.66%7.43%
Gross Profit
6.04B5.76B6.20B6.84B7.25B8.02B
Gross Margin
71.61%70.90%70.78%71.10%70.65%72.70%
Operating Income
1.71B1.48B1.62B1.87B2.19B3.89B
Net Income
-948.00M-225.00M-592.00M-46.00M157.00M-651.50M
EPS
----3.754.91
EPS Growth
-----4.94%30.97%
Forward PE
5.921.702.111.901.671.75
Free Cash Flow
----1.00B2.33B
No. Analysts
-----5
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High11.1B
Avg11.0B
Low10.9B

Revenue Growth

Revenue Growth202620272028
High
8.2%
Avg
7.4%
Low
6.4%

EPS Forecast

EPS202620272028
High5.33
Avg4.91
Low4.32

EPS Growth

EPS Growth202620272028
High
42.3%
Avg
31.0%
Low
15.3%